To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Condition(s):Psoriasis VulgarisLast Updated:August 19, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Psoriasis VulgarisLast Updated:August 19, 2020Completed
Condition(s):Androgenetic AlopeciaLast Updated:November 7, 2013Completed
Condition(s):HealthyLast Updated:October 15, 2021Completed
Condition(s):Androgenetic AlopeciaLast Updated:June 10, 2014Completed
Condition(s):PsoriasisLast Updated:January 3, 2018Completed
Condition(s):Acne VulgarisLast Updated:December 3, 2013Completed
Condition(s):Plaque PsoriasisLast Updated:November 20, 2020Unknown status
Condition(s):Androgenetic AlopeciaLast Updated:October 5, 2018Completed
Condition(s):Alopecia; Female Pattern Hair LossLast Updated:October 5, 2018Completed
Condition(s):Mild to Moderate PsoriasisLast Updated:August 10, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.